|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Type 2 diabetes mellitus.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN...
August 01, 2008
Selected websites.(Selected literature)
August 01, 2008
Vildagliptin.(Selected literature)(Brief article)
August 01, 2008
Liraglutide.(Selected literature)(Brief article)
August 01, 2008
Exenatide LAR.(Selected literature)(Brief article)
August 01, 2008
Raltegravir plus optimized background therapy superior to optimized ba...
August 01, 2008
Treatment with SSRIs or venlaxafine associated with increased risk of ...
August 01, 2008
Methotrexate plus etanercept effective in inducing clinical remission ...
August 01, 2008
Addition of aliskiren to losartan provides additional renal protective...
August 01, 2008
Clinical news updates from the 68th Scientific Sessions of the America...
August 01, 2008
Tocilizumab: a humanized anti-IL-6 receptor monoclonal antibody for th...
August 01, 2008
FDA has requested that a boxed warning regarding an increased risk of ...
August 01, 2008
FDA has issued an alert to healthcare professionals detailing the pote...
August 01, 2008
Dronedarone associated with increased mortality in patients with sever...
August 01, 2008
Durezol.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Pentacel.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Kinrix.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Aptivus.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Aciphex.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Requip XL.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Reclast.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Trivaris.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
PrandiMet.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Avodart.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Concerta.(FDA: actions in brief)(Drug overview)(Brief article)
August 01, 2008
Cymbalta: duloxetine.(New indications)(Drug overview)
August 01, 2008
First-time generic approval.(FDA Drug Approvals)(Drug overview)(Brief ...
August 01, 2008
DuoCort.(Orphan drug designations)(Drug overview)(Brief article)
August 01, 2008
Cysteamine.(Orphan drug designations)(Drug overview)(Brief article)
August 01, 2008
Ustekinumab.(Recommended for approval)(Drug overview)(Brief article)
August 01, 2008
Enbrel.(Recommended for approval)(Drug overview)(Brief article)
August 01, 2008
Tolvaptan.(Recommended for approval)(Drug overview)(Brief article)
August 01, 2008
Gardasil.(Complete response)(Drug overview)(Brief article)
August 01, 2008
Pancrealipase capsules.(Approvable designations)(Drug overview)(Brief ...
August 01, 2008
Nebido.(Approvable designations)(Drug overview)(Brief article)
August 01, 2008
Velcade: bortezomib.(New indications)(Drug overview)
August 01, 2008
Erythropoiesis-stimulating agents for anemia in older adults.(Clinical...
August 01, 2008
Safety surveillance to transform drug development and oversight.(Polic...
August 01, 2008
|